Nav: Home

Community interventions needed to close epilepsy treatment gap can be cost-effective

May 31, 2016

Most of epilepsy cases are treatable, yet in many parts of the world, including sub-Saharan Africa where the burden is amongst the world's highest, access to adequate treatment remains low. This results is significant stigma, avoidable harm and large societal costs. A doctoral dissertation from Umeå University suggests using community health workers to provide patient education and monitor medication adherence in a cost-effective way to reduce the epilepsy treatment gap.

"Our study adds to the health community's understanding of the epidemiology of epilepsy in rural South Africa and seriousness of the treatment gap in this context," says Ryan Wagner, researcher at the Department of Public Health and Clinical Medicine, Unit of Epidemiology and Global Health and author of the dissertation.

"Researchers and policymakers must urgently work together to identify interventions, such as the one we propose, that seek to reduce the epilepsy treatment gap and, ultimately, the burden of epilepsy."

Epilepsy is a common neurological disorder that affects 50 million individuals globally and indirectly impacts the lives of at least 500 million family members, friends and teachers of people with epilepsy. A majority of epilepsy cases are treatable with anti-epileptic drugs.

In his research, Ryan Wagner, who has a background in both neuroscience and field-based epidemiology, has followed a number of individuals in rural Agincourt, South Africa. Participants in the study were patients - both with and without epilepsy - within the Agincourt Health and Demographic Surveillance System. Using blood samples, Ryan Wagner and his research colleagues identified people who had epilepsy and determined how many of them were not adequately receiving or taking treatment, often referred to as the treatment gap.

The study results showed that 63 percent of people with epilepsy did not receive adequate treatment and were in fact in urgent need of an intervention. Employing local community health workers to counsel patients and monitor their adherence to medication for epilepsy, the researchers found, would be a cost-effective intervention to reduce the treatment gap, ultimately reducing the disease burden. Concretely, this would mean fewer seizures, improved productivity and likely less money spent on emergency care.

According to Ryan Wagner, recent attention given to epilepsy by the World Health Organization lends important political support and momentum for increased focus on a condition that for too long has been neglected in much of sub-Saharan Africa.

"Using sound epidemiology and population-based research sites, such as Agincourt, disease parameters can be measured and interventions modelled to determine their cost-effectiveness. Continued epilepsy research is essential in order to reduce the treatment gap for some of the world's most vulnerable populations," says Ryan Wagner, who is keen to continue this work in rural South Africa.
-end-
Ryan Wagner has spent the last eight years living and working in rural northeastern South Africa. In addition to his doctoral studies at the Department of Public Health and Clinical Medicine, Ryan is currently the acting Research Manager at the MRC/Wits Agincourt Research Unit within the School of Public Health, Faculty of Health Sciences at the University of the Witwatersrand, Johannesburg. The abovementioned research was supported by the European Union's Marie-Curie International Research Staff Exchange Scheme, the Umeå Centre for Global Health Research at Umeå University, through contributions from FAS and the Swedish Research School in Global Health. Additional support for the fieldwork was provided through the Priority Cost-effective Lessons for Systems Strengthening (PRICELESS) directorate, a sub-award through the University of Washington from the Bill & Melinda Gates Foundation and the Wellcome Trust.

Umea University

Related Epilepsy Articles:

Breaching the brain's defense causes epilepsy
Epileptic seizures can happen to anyone. But how do they occur and what initiates such a rapid response?
Using connectomics to understand epilepsy
Abnormalities in structural brain networks and how brain regions communicate may underlie a variety of disorders, including epilepsy, which is one focus of a two-part Special Issue on the Brain Connectome in Brain Connectivity, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Epilepsy: Triangular relationship in the brain
When an epileptic seizure occurs in the brain, the nerve cells lose their usual pattern and fire in a very fast rhythm.
How concussions may lead to epilepsy
Researchers have identified a cellular response to repeated concussions that may contribute to seizures in mice like those observed following traumatic brain injury in humans.
Understanding epilepsy in pediatric tumors
A KAIST research team led by Professor Jeong Ho Lee of the Graduate School of Medical Science and Engineering has recently identified a neuronal BRAF somatic mutation that causes intrinsic epileptogenicity in pediatric brain tumors.
Can medical marijuana help treat intractable epilepsy?
A new British Journal of Clinical Pharmacology review examines the potential of medicinal cannabis -- or medical marijuana -- for helping patients with intractable epilepsy, in which seizures fail to come under control with standard anticonvulsant treatment.
Fertility rates no different for women with epilepsy
'Myth-busting' study among women with no history of infertility finds that those with epilepsy are just as likely to become pregnant as those without.
Do women with epilepsy have similar likelihood of pregnancy?
Women with epilepsy without a history of infertility or related disorders who wanted to become pregnant were about as likely as their peers without epilepsy to become pregnant.
Hope for new treatment of severe epilepsy
Researchers at Lund University in Sweden believe they have found a method that in the future could help people suffering from epilepsy so severe that all current treatment is ineffective.
Many epilepsy patients take drug combinations that interact
In an Epilepsia analysis of 2008-2010 Medicare claims data, one in four older Americans with new-onset epilepsy and more than one-third with prevalent epilepsy received a combination of antiepileptic drugs and non-epilepsy drugs that could interact to alter the effectiveness of the non-epilepsy drugs.
More Epilepsy News and Epilepsy Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.